Product Information
CIMETIDINE 300 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2332 per EA under NDC 62135063190. Its NADAC has been published 100 times since Jul 31, 2024.
Strength
300 mg/1
Manufacturer
Chartwell RX LLCNDC
62135063190
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIMETIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA074329On Market Since
5/17/1994
Pharmacological Classes
Price Statistics
The NADAC for CIMETIDINE 300 MG TABLET has been published 100 times since Jul 31, 2024, and over the history we have for it it has risen 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2332 per EA |
|---|---|
| All-time high | $0.2899 (Jun 11, 2025) |
| All-time low | $0.2272 (Nov 20, 2024) |
| 52-week high | $0.2897 |
| 52-week low | $0.2332 |
| Median price | $0.2591 |
| Average price | $0.2600 |
| Largest weekly change | -20.2% (Nov 20, 2024) |
| Weeks tracked | 100 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIMETIDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 300 MG TABLET, manufactured by Chartwell RX LLC, is $0.2332 per EA (NDC 62135063190), effective Jun 24, 2026.
How has the price of CIMETIDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIMETIDINE 300 MG TABLET has risen 2.3%. It has been tracked across 100 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for CIMETIDINE 300 MG TABLET?
Since Jul 31, 2024, the NADAC for CIMETIDINE 300 MG TABLET has ranged from a low of $0.2272 (Nov 20, 2024) to a high of $0.2899 (Jun 11, 2025), with a median of $0.2591 per EA.
Are there cheaper alternatives to CIMETIDINE 300 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CIMETIDINE 300 MG TABLET, but none are currently priced below it.
Who manufactures CIMETIDINE 300 MG TABLET?
CIMETIDINE 300 MG TABLET (NDC 62135063190) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification